Template:Neonatal HSV antivirals: Difference between revisions
(minor edits to the initial - added meds for SBI eval (i.e. febrile neonate) - broadened options for ocular coverage) |
(Convert to AntibioticDose with disease=Meningitis for SMW linking) |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
=== | *{{AntibioticDose|disease=Meningitis|drug=Acyclovir|dose=20mg/kg IV q8hrs|context=Neonatal HSV duration depends on classification|population=Pediatric}} | ||
*If ocular involvement: | *If ocular involvement: | ||
**1% trifluridine, 0.1% iododeoxyuridine, or 3% vidarabine | **1% trifluridine, 0.1% iododeoxyuridine, or 3% vidarabine | ||
**Optho consult | **Optho consult | ||
*As for any febrile neonate SBI evaluation: | *As for any febrile neonate SBI evaluation: | ||
**Ampicillin + | **{{AntibioticDose|disease=Meningitis|drug=Ampicillin|dose=see age-based dosing|context=Neonatal HSV with SBI evaluation|population=Pediatric}} + [[Gentamicin]] | ||
***May substitute | ***May substitute [[Gentamicin]] with [[Cefotaxime]]/[[Ceftazidime]] | ||
Latest revision as of 01:49, 20 March 2026
- Acyclovir 20mg/kg IV q8hrs
- If ocular involvement:
- 1% trifluridine, 0.1% iododeoxyuridine, or 3% vidarabine
- Optho consult
- As for any febrile neonate SBI evaluation:
- Ampicillin see age-based dosing + Gentamicin
- May substitute Gentamicin with Cefotaxime/Ceftazidime
- Ampicillin see age-based dosing + Gentamicin